Detalhe da pesquisa
1.
Genomics to select treatment for patients with metastatic breast cancer.
Nature
; 610(7931): 343-348, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071165
2.
Author Correction: Genomic characterization of metastatic breast cancers.
Nature
; 572(7767): E7, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31308536
3.
Genomic characterization of metastatic breast cancers.
Nature
; 569(7757): 560-564, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118521
4.
Pattern and risk factors of isolated local relapse among women with hormone receptor-positive and HER2-negative breast cancer and lymph node involvement: 10-year follow-up analysis of the PACS 01 and PACS 04 trials.
Breast Cancer Res Treat
; 199(2): 371-379, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36988749
5.
Association between progression-free survival and overall survival in women receiving first-line treatment for metastatic breast cancer: evidence from the ESME real-world database.
BMC Med
; 21(1): 87, 2023 03 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36882736
6.
Association of Radiochemotherapy to Immunotherapy in unresectable locally advanced Oesophageal carciNoma-randomized phase 2 trial ARION UCGI 33/PRODIGE 67: the study protocol.
BMC Cancer
; 23(1): 966, 2023 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37828434
7.
New late-emphasis and combination tests based on infimum and supremum logrank statistics with application in oncology trials.
Stat Med
; 42(12): 1981-1994, 2023 05 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37002623
8.
PARa-aOrtic LymphAdenectomy in locally advanced cervical cancer (PAROLA trial): a GINECO, ENGOT, and GCIG study.
Int J Gynecol Cancer
; 33(2): 293-298, 2023 02 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36717163
9.
Multigene Panel Sequencing Identifies a Novel Germline Mutation Profile in Male Breast Cancer Patients.
Int J Mol Sci
; 24(18)2023 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762649
10.
Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
Br J Cancer
; 127(11): 1963-1973, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36207609
11.
CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
Mod Pathol
; 35(12): 2002-2010, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36202996
12.
Study protocol of the TEC-ORL clinical trial: a randomized comparative phase II trial investigating the analgesic activity of capsaicin vs Laroxyl in head and neck Cancer survivors presenting with neuropathic pain sequelae.
BMC Cancer
; 22(1): 1260, 2022 Dec 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36471253
13.
A stratified adaptive two-stage design with co-primary endpoints for phase II clinical oncology trials.
BMC Med Res Methodol
; 22(1): 278, 2022 10 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-36289451
14.
Functional and oncological outcomes of salvage transoral robotic surgery: a comparative study.
Eur Arch Otorhinolaryngol
; 279(1): 457-466, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33880636
15.
Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study.
Breast Cancer Res
; 23(1): 61, 2021 05 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-34039396
16.
Improving patient selection for immuno-oncology phase 1 trials: External validation of six prognostic scores in a French Cancer Center.
Int J Cancer
; 148(10): 2502-2511, 2021 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33231298
17.
Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer.
Anal Chem
; 93(15): 6104-6111, 2021 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-33825439
18.
Impact of a comprehensive geriatric assessment on decision-making in older patients with hematological malignancies.
Eur J Haematol
; 106(5): 616-626, 2021 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-33340150
19.
Modernizing adverse events analysis in oncology clinical trials using alternative approaches: rationale and design of the MOTIVATE trial.
Invest New Drugs
; 38(6): 1879-1887, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32383099
20.
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: study protocol of the target selection phase III CHIC-STS trial.
BMC Cancer
; 20(1): 716, 2020 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32736540